Building an unconventional practice and looking for the right clients and collaborative network to build it with.
15+ inbound inquiries this summer for technology commercialization and IP licensing work confirm real underserved demand. Now looking to build the right collaborative network around it.
Building an unconventional practice and looking for the right clients and collaborative network to build it with.
A quick update: during summer I have had 15+ inbound inquiries for technology commercialization and IP licensing work from individual innovators, startups, innovation units inside established companies, a couple of SMEs, and even a utility corporation.
🌍 Mostly from Europe, with interest also coming from South America and the Middle East.
It confirms something I believed going in: there is real underserved demand for someone who can move technology across borders and match it to the right buyer, investor, or partner, in an efficient and effective way by leveraging technology and connecting dots.
While none of these are closed mandates yet, 2 conversations are progressing towards assessing mutual fit, especially around cleantech where I can add most value from my experience in energy generation. ⚡
Who do I want to build this with? I seek to reach the other end of this market:
→ Investment funds backing technology-driven startups, looking for deal flow origination.
→ Larger companies seeking innovation for their products or operations. I can map relevant technology providers and acquirable targets.
→ European universities, for long-term collaboration around commercializing past and ongoing research outputs. Providing real market perspective and active outreach, and outcomes.
I am also actively exploring how to structure collaborations with partners so that scale stops being a barrier to engage with large corporations.
🤝
If any of this resonates with you or someone you know. Let's talk!
About the author
Felipe Branch is a cross-border transaction advisor specialising in renewable energy infrastructure and IP commercialization. He works with institutional investors, technology companies, and research institutions across Europe.